Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 4, 2009 - Issue 10
Submit an article Journal homepage
307
Views
38
CrossRef citations to date
0
Altmetric
Reviews

Advances in nuclear magnetic resonance for drug discovery

Robert Powers University of Nebraska-Lincoln, Department of Chemistry, 722 Hamilton Hall, Lincoln, NE 68588-0304, USA +1 402 472 3039; +1 402 472 2044; [email protected]
Pages 1077-1098 | Published online: 28 Aug 2009

Bibliography

  • Sams-Dodd F. Target-based drug discovery: is something wrong? Drug Discov Today 2005;10(2):139-47
  • Garnier J-P. Rebuilding the R&D engine in big pharma. Harv Bus Rev 2008;86(5):68-70, 2-6, 128
  • Weisbach JA, Moos WH. Diagnosing the decline of major pharmaceutical research laboratories: a prescription for drug companies. Drug Dev Res 1995;34(3):243-59
  • Horrobin DF. Realism in drug discovery-could Cassandra be right? Nat Biotechnol 2001;19(12):1099-100
  • Cuatrecasas P. Drug discovery in jeopardy. J Clin Invest 2006;116(11):2837-42
  • Kola I, Landis J. Opinion: can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 2004;3(8):711-6
  • Caldwell GW, Ritchie DM, Masucci JA, et al. The new pre-preclinical paradigm: compound optimization in early and late phase drug discovery. Curr Top Med Chem (Hilversum, Netherlands) 2001;1(5):353-66
  • Dickson M, Gagnon JP. Key factors in the rising cost of new drug discovery and development. Nat Rev Drug Discov 2004;3(5):417-29
  • Karlberg JPE. Trends in disease focus of drug development. Nat Rev Drug Discov 2008;7(8):639-40
  • Owens J. Big pharma slims down to bolster productivity. Nat Rev Drug Discov 2007;6(3):173-4
  • Wermuth CG. Similarity in drugs: reflections on analogue design. Drug Discov Today 2006;11(7 & 8):348-54
  • Booth B, Zemmel R. Opinion: quest for the best. Nat Rev Drug Discov 2003;2(10):838-41
  • Zhong X, Moseley GB, III. Mission possible: managing innovation in drug discovery. Nat Biotechnol 2007;25(8):945-6
  • Booth B, Zemmel R. Prospects for productivity. Nat Rev Drug Discov 2004;3(5):451-6
  • Cavalla D. The extended pharmaceutical enterprise. Drug Discov Today 2003;8(6):267-74
  • Frantz S. Chemistry outsourcing going global. Nat Rev Drug Discov 2006;5(5):362-3
  • Ullman F, Boutellier R. Drug discovery: are productivity metrics inhibiting motivation and creativity? Drug Discov Today 2008;13(21/22):997-1001
  • Ullman F, Boutellier R. A case study of lean drug discovery: from project driven research to innovation studios and process factories. Drug Discov Today 2008;13(11/12):543-50
  • Mackay M, Street SDA, McCall JM. Risk reduction in drug discovery and development. Curr Top Med Chem (Sharjah, United Arab Emirates) 2005;5(11):1087-90
  • Lewis CT, O'Connor PM. Discovering novel anticancer drugs: practical aspects and recent advances. Methods Mol Biol (Totowa, NJ, US) 2003;223 (Tumor Suppressor Genes, Volume 2):425-63
  • Senn S. Some statistical issues in project prioritization in the pharmaceutical industry. Stat Med 1996;15(24):2689-702
  • Schmid Esther F, Smith Dennis A. Is pharmaceutical R&D just a game of chance or can strategy make a difference? Drug Discov Today 2004;9(1):18-26
  • Handen Jeffrey S. The industrialization of drug discovery. Drug Discov Today 2002;7(2):83-5
  • Pichler FB, Turner SJ. The power and pitfalls of outsourcing. Nat Biotechnol 2007;25(10):1093-6
  • Adam M. What to expect from rational drug design. Expert Opin Drug Discov 2007;2(6):773-6
  • Sams-Dodd F. Drug discovery: selecting the optimal approach. Drug Discov Today 2006;11(9 & 10):465-72
  • Lahana R. How many leads from HTS? Drug Discov Today 1999;4(10):447-8
  • McGovern SL, Caselli E, Grigorieff N, Shoichet BK. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem 2002;45(8):1712-22
  • McGovern SL, Helfand BT, Feng B, Shoichet BK. A specific mechanism of nonspecific inhibition. J Med Chem 2003;46(20):4265-72
  • Rishton GM. Reactive compounds and in vitro false positives in HTS. Drug Discov Today 1997;2(9):382-4
  • Seidler J, McGovern SL, Doman TN, Shoichet BK. Identification and prediction of promiscuous aggregating inhibitors among known drugs. J Med Chem 2003;46(21):4477-86
  • Kubinyi H. Opinion: drug research: myths, hype and reality. Nat Rev Drug Discov 2003;2(8):665-8
  • Pellecchia M, Bertini I, Cowburn D, et al. Perspectives on NMR in drug discovery: a technique comes of age. Nat Rev Drug Discov 2008;7(9):738-45
  • Davis B, Hubbard J. Applications of NMR in structure-based drug discovery. Struct-Based Drug Discov 2006;97-141
  • Zartler ER, Shapiro MJ. Protein NMR-based screening in drug discovery. Curr Pharm Des 2006;12(31):3963-72
  • Jahnke W. Perspectives of biomolecular NMR in drug discovery: the blessing and curse of versatility. J Biomol NMR 2007;39(2):87-90
  • Snyder DA, Chen Y, Denissova NG, et al. Comparisons of NMR spectral quality and success in crystallization demonstrate that NMR and X-ray crystallography are complementary methods for small protein structure determination. J Am Chem Soc 2005;127(47):16505-11
  • Yee AA, Savchenko A, Ignachenko A, et al. NMR and X-ray crystallography, complementary tools in structural proteomics of small proteins. J Am Chem Soc 2005;127(47):16512-7
  • Montelione GT, Arrowsmith C, Girvin ME, et al. Unique opportunities for NMR methods in structural genomics. J Struct Funct Genomics 2009;10(2):101-6
  • Sprangers R, Gribun A, Hwang PM, et al. Quantitative NMR spectroscopy of supramolecular complexes: dynamic side pores in ClpP are important for product release. Proc Natl Acad Sci USA 2005;102(46):16678-83
  • Jain NU, Wyckoff TJO, Raetz CRH, Prestegard JH. Rapid analysis of large protein-protein complexes using NMR-derived orientational constraints: the 95kDa complex of LpxA with acyl carrier protein. J Mol Biol 2004;343(5):1379-89
  • Tugarinov V, Muhandiram R, Ayed A, Kay LE. Four-dimensional NMR spectroscopy of a 723-residue protein: chemical shift assignments and secondary structure of malate synthase G. J Am Chem Soc 2002;124(34):10025-35
  • Tugarinov V, Kay LE. Quantitative 13C and 2H NMR relaxation studies of the 723-residue enzyme malate synthase G reveal a dynamic binding interface. Biochemistry 2005;44(49):15970-7
  • Peterson FC, Gettins PGW. Insight into the mechanism of serpin-proteinase inhibition from 2D [1H-15N] NMR studies of the 69 kDa a1-proteinase inhibitor Pittsburgh-trypsin covalent complex. Biochemistry 2001;40(21):6284-92
  • Liu D, Wang Y-S, Gesell JJ, et al. Backbone resonance assignments of the 45.3 kDa catalytic domain of human BACE1. J Biomol NMR 2004;29(3):425-6
  • Revington M, Zuiderweg ERP. Letter to the editor: TROSY-driven NMR backbone assignments of the 381-residue nucleotide-binding domain of the Thermus thermophilus DnaK molecular chaperone. J Biomol NMR 2004;30(1):113-4
  • Amero C, Schanda P, Dura MA, et al. Fast two-dimensional NMR spectroscopy of high molecular weight protein assemblies. J Am Chem Soc 2009;131(10):3448-9
  • Mukrasch MD, Bibow S, Korukottu J, et al. Structural polymorphism of 441-residue tau at single residue resolution. PLoS Biol 2009;7(2):399-414
  • LeMaster DM. Deuterium labeling in NMR structural analysis of larger proteins. Q Rev Biophys 1990;23(2):133-74
  • Kigawa T, Muto Y, Yokoyama S. Cell-free synthesis and amino acid-selective stable isotope labeling of proteins for NMR analysis. J Biomol NMR 1995;6(2):129-34
  • Goto NK, Kay LE. New developments in isotope labeling strategies for protein solution NMR spectroscopy. Curr Opin Struct Biol 2000;10(5):585-92
  • Zhu G, Yao X. TROSY-based NMR experiments for NMR studies of large biomolecules. Prog Nucl Magn Reson Spectrosc 2008;52(1):49-68
  • Keppetipola S, Kudlicki W, Nguyen BD, et al. From gene to HSQC in under five hours: high-throughput NMR proteomics. J Am Chem Soc 2006;128(14):4508-9
  • Vinarov DA, Markley JL. High-throughput automated platform for nuclear magnetic resonance-based structural proteomics. Expert Rev Proteomics 2005;2(1):49-55
  • Folkers GE, van Buuren BNM, Kaptein R. Expression screening, protein purification and NMR analysis of human protein domains for structural genomics. J Struct Funct Genomics 2004;5(1-2):119-31
  • Ozawa K, Headlam MJ, Schaeffer PM, et al. Optimization of an Escherichia coli system for cell-free synthesis of selectively 15N-labelled proteins for rapid analysis by NMR spectroscopy. Eur J Biochem 2004;271(20):4084-93
  • de Alba E, Tjandra N. Residual dipolar couplings in protein structure determination. Methods Mol Biol (Totowa, NJ, US) 2004;278 (Protein NMR techniques):89-106
  • Clore GM, Starich MR, Bewley CA, et al. Impact of residual dipolar couplings on the accuracy of NMR structures determined from a minimal number of NOE restraints. J Am Chem Soc 1999;121(27):6513-4
  • Huang X, Moy F, Powers R. Evaluation of the utility of NMR structures determined from minimal NOE-based restraints for structure-based drug design, using MMP-1 as an example. Biochemistry 2000;39(44):13365-75
  • Gaponenko V, Sarma SP, Altieri AS, et al. Improving the accuracy of NMR structures of large proteins using pseudocontact shifts as long-range restraints. J Biomol NMR 2004;28(3):205-12
  • Huang YJ, Moseley HNB, Baran MC, et al. An integrated platform for automated analysis of protein NMR structures. Methods Enzymol 2005;394(NMR of Biological Macromolecules, Part C):111-41
  • Acton TB, Gunsalus KC, Xiao R, et al. Robotic cloning and protein production platform of the northeast structural genomics consortium. Methods Enzymol 2005;394(NMR of Biological Macromolecules, Part C):210-43
  • Hiller S, Fiorito F, Wuethrich K, Wider G. Automated projection spectroscopy (APSY). Proc Natl Acad Sci USA 2005;102(31):10876-81
  • Liu G, Shen Y, Atreya HS, et al. NMR data collection and analysis protocol for high-throughput protein structure determination. Proc Natl Acad Sci USA 2005;102(30):10487-92
  • Atreya HS, Szyperski T. G-matrix fourier transform NMR spectroscopy for complete protein resonance assignment. Proc Natl Acad Sci USA 2004;101(26):9642-7
  • Eghbalnia HR, Bahrami A, Tonelli M, et al. High-resolution iterative frequency identification for NMR as a general strategy for multidimensional data collection. J Am Chem Soc 2005;127(36):12528-36
  • Coggins BE, Venters RA, Zhou P. Filtered backprojection for the reconstruction of a high-resolution (4,2)D CH3-NH NOESY spectrum on a 29 kDa protein. J Am Chem Soc 2005;127(33):11562-3
  • Staykova DK, Fredriksson J, Bermel W, Billeter M. Assignment of protein NMR spectra based on projections, multi-way decomposition and a fast correlation approach. J Biomol NMR 2008;42(2):87-97
  • Szyperski T, Yeh DC, Sukumaran DK, et al. Reduced-dimensionality NMR spectroscopy for high-throughput protein resonance assignment. Proc Natl Acad Sci USA 2002;99(12):8009-14
  • Rovnyak D, Frueh DP, Sastry M, et al. Accelerated acquisition of high resolution triple-resonance spectra using non-uniform sampling and maximum entropy reconstruction. J Magn Reson 2004;170(1):15-21
  • Mobli M, Stern AS, Hoch JC. Spectral reconstruction methods in fast NMR: reduced dimensionality, random sampling and maximum entropy. J Magn Reson 2006;182(1):96-105
  • Hoch JC, Maciejewski MW, Filipovic B. Randomization improves sparse sampling in multidimensional NMR. J Magn Reson 2008;193(2):317-20
  • Mandelshtam VA, Taylor HS, Shaka AJ. Application of the filter diagonalization method to one- and two-dimensional NMR spectra. J Magn Reson 1998;133(2):304-12
  • Schmieder P, Stern AS, Wagner G, Hoch JC. Improved resolution in triple-resonance spectra by nonlinear sampling in the constant-time domain. J Biomol NMR 1994;4(4):483-90
  • Orekhov VY, Ibraghimov I, Billeter M. Optimizing resolution in multidimensional NMR by three-way decomposition. J Biomol NMR 2003;27(2):165-73
  • Orekhov VY, Ibraghimov IV, Billeter M. MUNIN: a new approach to multi-dimensional NMR spectra interpretation. J Biomol NMR 2001;20(1):49-60
  • Kazimierczuk K, Zawadzka A, Kozminski W. Optimization of random time domain sampling in multidimensional NMR. J Magn Reson 2008;192(1):123-30
  • Kazimierczuk K, Zawadzka A, Kozminski W, Zhukov I. Random sampling of evolution time space and Fourier transform processing. J Biomol NMR 2006;36(3):157-68
  • Kazimierczuk K, Kozminski W, Zhukov I. Two-dimensional fourier transform of arbitrarily sampled NMR data sets. J Magn Reson 2006;179(2):323-8
  • Kazimierczuk K, Zawadzka A, Kozminski W, Zhukov I. Lineshapes and artifacts in multidimensional fourier transform of arbitrary sampled NMR data sets. J Magn Reson 2007;188(2):344-56
  • Schanda P, Van Melckebeke H, Brutscher B. Speeding Up three-dimensional protein NMR experiments to a few minutes. J Am Chem Soc 2006;128(28):9042-3
  • Schanda P, Kupce E, Brutscher B. SOFAST-HMQC experiments for recording two-dimensional heteronuclear correlation spectra of proteins within a few Seconds. J Biomol NMR 2005;33(4):199-211
  • Moseley HNB, Monleon D, Montelione GT. Automatic determination of protein backbone resonance assignments from triple resonance nuclear magnetic resonance data. Methods Enzymol 2001;339(NMR of Biological Macromolecules, Part B):91-108
  • Zimmerman DE, Kulikowski CA, Huang Y, et al. Automated analysis of protein NMR assignments using methods from artificial intelligence. J Mol Biol 1997;269(4):592-610
  • Lescop E, Brutscher B. Highly automated protein backbone resonance assignment within a few hours: the ‘BATCH’ strategy and software package. J Biomol NMR 2009;44(1):43-57
  • Bartels C, Billeter M, Guentert P, Wuethrich K. Automated sequence-specific NMR assignment of homologous proteins using the program GARANT. J Biomol NMR 1996;7(3):207-13
  • Schmucki R, Yokoyama S, Guentert P. Automated assignment of NMR chemical shifts using peak-particle dynamics simulation with the DYNASSIGN algorithm. J Biomol NMR 2009;43(2):97-109
  • Lin H-N, Wu K-P, Chang J-M, et al. GANA - a genetic algorithm for NMR backbone resonance assignment. Nucleic Acids Res 2005;33(14):4593-601
  • Volk J, Herrmann T, Wuthrich K. Automated sequence-specific protein NMR assignment using the memetic algorithm MATCH. J Biomol NMR 2008;41(3):127-38
  • Eghbalnia HR, Bahrami A, Wang L, et al. Probabilistic Identification of Spin Systems and their Assignments including Coil-Helix Inference as Output (PISTACHIO). J Biomol NMR 2005;32(3):219-33
  • Ferentz AE, Wagner G. NMR spectroscopy: a multifaceted approach to macromolecular structure. Q Rev Biophys 2000;33(1):29-65
  • Guentert P. Automated structure determination from NMR spectra. Eur Biophys J 2009;38(2):129-43
  • Huang YJ, Tejero R, Powers R, Montelione GT. A topology-constrained distance network algorithm for protein structure determination from NOESY data. Proteins Struct Funct Bioinform 2006;62(3):587-603
  • Rieping W, Habeck M, Bardiaux B, et al. ARIA2: automated NOE assignment and data integration in NMR structure calculation. Bioinformatics 2007;23(3):381-2
  • Grishaev A, Llinas M. Protein structure elucidation from minimal NMR data: the CLOUDS approach. Methods Enzymol 2005;394(Nuclear Magnetic Resonance of Biological Macromolecules, Part C):261-95
  • Guntert P. Automated NMR structure calculation with CYANA. Methods Mol Biol (Totowa, NJ, US) 2004;278(Protein NMR Techniques):353-78
  • Kuszewski J, Schwieters CD, Garrett DS, et al. Completely automated, highly error-tolerant macromolecular structure determination from multidimensional nuclear overhauser enhancement spectra and chemical shift assignments. J Am Chem Soc 2004;126(20):6258-73
  • Lopez-Mendez B, Guentert P. Automated protein structure determination from NMR spectra. J Am Chem Soc 2006;128(40):13112-22
  • Rohl CA. Protein structure estimation from minimal restraints using Rosetta. Methods Enzymol 2005;394(NMR of Biological Macromolecules, Part C):244-60
  • Schwieters CD, Kuszewski JJ, Clore GM. Using Xplor-NIH for NMR molecular structure determination. Prog Nucl Magn Reson Spectrosc 2006;48(1):47-62
  • Mal TK, Bagby S, Ikura M. Protein structure calculation from NMR data. Methods Mol Biol (Totowa, NJ, US) 2002;173(Calcium-Binding Protein Protocols, Volume 2):267-83
  • Jee J, Guentert P. Influence of the completeness of chemical shift assignments on NMR structures obtained with automated NOE assignment. J Struct Funct Genomics 2003;4(2-3):179-89
  • Herrmann T, Gntert P, Wthrich K. Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J Mol Biol 2002;319(1):209-27
  • Guntert P. Automated NMR protein structure calculation. Prog Nucl Magn Reson Spectrosc 2003;43(3-4):105-25
  • Delaglio F, Kontaxis G, Bax A. Protein structure determination using molecular fragment replacement and NMR dipolar couplings. J Am Chem Soc 2000;122(9):2142-3
  • Prestegard JH, Mayer KL, Valafar H, Benison GC. Determination of protein backbone structures from residual dipolar couplings. Methods Enzymol 2005;394(NMR of Biological Macromolecules, Part C):175-209
  • Shen Y, Vernon R, Baker D, Bax A. De novo protein structure generation from incomplete chemical shift assignments. J Biomol NMR 2009;43(2):63-78
  • Bhattacharya A, Tejero R, Montelione GT. Evaluating protein structures determined by structural genomics consortia. Proteins Struct Funct Bioinform 2007;66(4):778-95
  • Chakravarti B, Lewis SJ, Chakravarti DN, Raval A. Three dimensional structures of proteins and protein complexes from chemical cross-linking and mass spectrometry: a biochemical and computational overview. Curr Proteomics 2006;3(1):1-21
  • Mori S, Abeygunawardana C, Johnson MON, van Zijl PCM. Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation. J Magn Reson Ser B 1995;108(1):94-8
  • Haner RL, Llanos W, Mueller L. Small volume flow probe for automated direct-injection NMR analysis: design and performance. J Magn Reson 2000;143(1):69-78
  • Stark J, Powers R. Rapid protein-ligand costructures using chemical shift perturbations. J Am Chem Soc 2008;130(2):535-45
  • Morris GM, Goodsell DS, Halliday RS, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 1998;19(14):1639-62
  • Huey R, Morris GM, Olson AJ, Goodsell DS. A semiempirical free energy force field with charge-based desolvation. J Comput Chem 2007;28(6):1145-52
  • Loll PJ, Lattman EE. The crystal structure of the ternary complex of staphylococcal nuclease, calcium, and the inhibitor pdTp, refined at 1.65 Ã. Proteins Struct Funct Genet 1989;5(3):183-201
  • Dominguez C, Boelens R, Bonvin AMJJ. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc 2003;125(7):1731-7
  • Nilges M. Ambiguous distance data in the calculation of NMR structures. Folding Des 1997;2(4):S53-S7
  • Zhang N, Liu LH, Liu F, et al. NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity. J Mol Biol 2006;363(1):188-200
  • Moy FJ, Chanda PK, Chen JM, et al. NMR solution structure of the catalytic fragment of human fibroblast collagenase complexed with a sulfonamide derivative of a hydroxamic acid compound. Biochemistry 1999;38(22):7085-96
  • Chen JM, Nelson FC, Levin JI, et al. Structure-based design of a novel, potent, and selective inhibitor for MMP-13 utilizing NMR spectroscopy and computer-aided molecular design. J Am Chem Soc 2000;122(40):9648-54
  • John M, Pintacuda G, Park AY, et al. Structure determination of protein-ligand complexes by transferred paramagnetic shifts. J Am Chem Soc 2006;128(39):12910-6
  • Medek A, Hajduk PJ, Mack J, Fesik SW. The use of differential chemical shifts for determining the binding site location and orientation of protein-bound ligands. J Am Chem Soc 2000;122(6):1241-2
  • Hajduk PJ, Mack JC, Olejniczak ET, et al. SOS-NMR: a Saturation transfer NMR-based method for determining the structures of protein-ligand complexes. J Am Chem Soc 2004;126(8):2390-8
  • Sem DS, Yu L, Coutts SM, Jack R. Object-oriented approach to drug design enabled by NMR SOLVE: first real-time structural tool for characterizing protein-ligand interactions. J Cell Biochem 2001(Suppl 37):99-105
  • Pellecchia M, Meininger D, Dong Q, et al. NMR-based structural characterization of large protein-ligand interactions. J Biomol NMR 2002;22(2):165-73
  • Metzler WJ, Claus BL, McDonnell PA, et al. Application of protein-ligand NOE matching to the rapid evaluation of fragment binding poses. Fragm-Based Drug Discov 2008;99-133
  • Dove A, Marshall A. Drug screening-beyond the bottleneck. Nat Biotechnol 1999;17(9):859-63
  • Goode DR, Totten RK, Heeres JT, Hergenrother PJ. Identification of promiscuous small molecule activators in high-throughput enzyme activation screens. J Med Chem 2008;51(8):2346-9
  • Lipinski CA. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 2001;44(1):235-49
  • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23(1-3):3-25
  • Andrews CW, Bennett L, Yu LX. Predicting human oral bioavailability of a compound: development of a novel quantitative structure-bioavailability relationship. Pharm Res 2000;17(6):639-44
  • Viswanadhan VN, Balan C, Hulme C, et al. Knowledge-based approaches in the design and selection of compound libraries for drug discovery. Curr Opin Drug Discov Devel 2002;5(3):400-6
  • Matter H, Baringhaus K-H, Naumann T, et al. Computational approaches towards the rational design of drug-like compound libraries. Comb Chem High Throughput Screen 2001;4(6):453-75
  • Xu J, Stevenson J. Drug-like index: a new approach to measure drug-like compounds and their diversity. J Chem Inf Comput Sci 2000;40(5):1177-87
  • Jelic D, Mesar V, Basic I, et al. Novel approach to drug discovery in PLIVA - establishing of HTS unit and unique compounds library. PharmaChem 2003;2(6):64-7
  • Xue L, Bajorath J. Molecular descriptors in chemoinformatics, computational combinatorial chemistry, and virtual screening. Comb Chem High Throughput Screen 2000;3(5):363-72
  • Lewis RA, Pickett SD, Clark DE. Computer-aided molecular diversity analysis and combinatorial library design. Rev Comput Chem 2000;16:1-51
  • Willett P. Chemoinformatics - similarity and diversity in chemical libraries. Curr Opin Biotechnol 2000;11(1):85-8
  • Spellmeyer DC, Grootenhuis PDJ. Recent developments in molecular diversity. Computational approaches to combinatorial chemistry. Annu Rep Med Chem 1999;34:287-96
  • Gorse D, Lahana R. Functional diversity of compound libraries. Curr Opin Chem Biol 2000;4(3):287-94
  • Villar HO, Koehler RT. Comments on the design of chemical libraries for screening. Mol Divers 2000;5(1):13-24
  • Bohacek RS, McMartin C, Guida WC. The art and practice of structure-based drug design: a molecular modeling perspective. Med Res Rev 1996;16(1):3-50
  • Mestres J, Veeneman GH. Identification of “Latent Hits” in compound screening collections. J Med Chem 2003;46(16):3441-4
  • Kozikowski BA, Burt TM, Tirey DA, et al. The effect of freeze/thaw cycles on the stability of compounds in DMSO. J Biomol Screen 2003;8(2):210-5
  • Kozikowski BA, Burt TM, Tirey DA, et al. The effect of room-temperature storage on the stability of compounds in DMSO. J Biomol Screen 2003;8(2):205-9
  • Posner BA. High-throughput screening-driven lead discovery: meeting the challenges of finding new therapeutics. Curr Opin Drug Discov Devel 2005;8(4):487-94
  • Jahnke W. Fragment-based approaches. Compr Med Chem II 2006;3:939-57
  • Schultz J. Practical aspects of using NMR in fragment-based screening. Fragm-Based Drug Discov 2008;63-98
  • Gribbon P, Sewing A. High-throughput drug discovery: what can we expect from HTS? Drug Discov Today 2005;10(1):17-22
  • Schmitt W, Willmann S. Physiology-based pharmacokinetic modeling: ready to be used. Drug Discov Today Technol 2004;1(4):449-56
  • Wienkers LC, Heath TG. Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov 2005;4(10):825-33
  • Zimmerman RJ. How and when to apply absorption, distribution, metabolism, excretion, and toxicity. Compr Med Chem II 2006;2:559-72
  • Korfmacher W. Strategies and techniques for higher throughput ADME/PK assays. High-Throughput Anal Pharm Ind 2009;205-31
  • Schuffenhauer A, Ruedisser S, Marzinzik AL, et al. Library design for fragment based screening. Curr Top Med Chem (Sharjah, United Arab Emirates) 2005;5(8):751-62
  • Erlanson DA. Fragment-based lead discovery: a chemical update. Curr Opin Biotechnol 2006;17(6):643-52
  • Jencks WP. On the attribution and additivity of binding energies. Proc Natl Acad Sci USA 1981;78(7):4046-50
  • Fischer M, Hubbard RE. Fragment-based ligand discovery. Mol Interv 2009;9(1):22-30
  • Congreve M, Murray CW, Carr R, Rees DC. Fragment-based lead discovery. Annu Rep Med Chem 2007;42:431-48
  • Siegal G, Ab E, Schultz J. Integration of fragment screening and library design. Drug Discov Today 2007;12(23&24):1032-9
  • Mercier KA, Germer K, Powers R. Design and characterization of a functional library for NMR screening against novel protein targets. Comb Chem High Throughput Screen 2006;9(7):515-34
  • Hopkins Andrew L, Groom Colin R, Alex A. Ligand efficiency: a useful metric for lead selection. Drug Discov Today 2004;9(10):430-1
  • Fink T, Bruggesser H, Reymond J-L. Virtual exploration of the small-molecule chemical universe below 160 D. Angew Chem Int Ed 2005;44(10):1504-8
  • Hajduk PJ. SAR by NMR: putting the pieces together. Mol Interv 2006;6(5):266-72
  • Hajduk PJ, Greer J. A decade of fragment-based drug design: strategic advances and lessons learned. Nat Rev Drug Discov 2007;6(3):211-9
  • Mayr LM, Fuerst P. The future of high-throughput screening. J Biomol Screen 2008;13(6):443-8
  • Schade M. Fragment-based lead discovery by NMR. Front Drug Des Discov 2007;3:105-19
  • Clore GM, Gronenborn AM. Structures of larger proteins, protein-ligand and protein-DNA complexes by multidimensional heteronuclear NMR. Protein Sci 1994;3:372-90
  • Cooke RM. Protein NMR extends into new fields of structural biology. Curr Opin Chem Biol 1997;1(3):359-64
  • Kay LE. NMR methods for the study of protein structure and dynamics. Biochem Cell Biol 1997;75(1):1-15
  • Roberts GCK. Applications of NMR in drug discovery. Drug Discov Today 2000;5(6):230-40
  • Rossi C, Donati A, Sansoni MR. Nuclear magnetic resonance as a tool for the identification of specific DNA-ligand interaction. Chem Phys Lett 1992;189(3):278-80
  • Hajduk PJ, Olejniczak ET, Fesik SW. One-dimensional relaxation- and diffusion-edited NMR methods for screening compounds that bind to macromolecules. J Am Chem Soc 1997;119(50):12257-61
  • Lin M, Shapiro MJ, Wareing JR. Screening mixtures by affinity NMR. J Org Chem 1997;62(25):8930-1
  • Lin M, Shapiro MJ, Wareing JR. Diffusion-edited NMR-affinity NMR for direct observation of molecular interactions. J Am Chem Soc 1997;119(22):5249-50
  • Waldeck AR, Kuchel PW, Lennon AJ, Chapman BE. NMR diffusion measurements to characterize membrane transport and solute binding. Prog Nucl Magn Reson Spectrosc 1997;30(1-2):39-68
  • Wüthrich K. NMR of proteins and nucleic acids. New York: John Wiley & Sons, Inc.; 1986
  • Shirakawa M, Lee SJ, Takimoto M, et al. Interaction of the l-cro repressor protein with operator DNA fragments monitored as to amide proton magnetic resonances. J Mol Struct 1991;242:355-66
  • Otting G. Experimental NMR techniques for studies of protein-ligand interactions. Curr Opin Struct Biol 1993;3(5):760-8
  • Ni F. Recent developments in transferred NOE methods. Prog Nucl Magn Reson Spectrosc 1994;26(6):517-606
  • Vogtherr M, Peters T. Application of NMR based binding assays to identify key hydroxy groups for intermolecular recognition. J Am Chem Soc 2000;122(25):6093-9
  • Mayer M, Meyer B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew Chem, Int Ed 1999;38(12):1784-8
  • Dalvit C, Pevarello P, Tato M, et al. Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water. J Biomol NMR 2000;18(1):65-8
  • Chen A, Shapiro MJ. NOE pumping: a novel NMR technique for identification of compounds with binding affinity to macromolecules. J Am Chem Soc 1998;120(39):10258-9
  • Edwards PD, Albert JS, Sylvester M, et al. Application of fragment-based lead generation to the discovery of novel, cyclic amidine Î2-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency. J Med Chem 2007;50(24):5912-25
  • Dixon AK, Fisch HU. Animal models and ethological strategies for early drug-testing in humans. Neurosci Biobehav Rev 1998;23(2):345-58
  • Preziosi P. Predictive values of animal versus clinical testing in drug evaluation, problems and difficulties. Adv Clin Pharmacol 1977;13(Probl Clin Pharmacol Ther Res: Phase 1 Proc Int Symp Clin Pharmacol 14th):41-69
  • Fox TM. Strains and species variations in pharmacological responses. Symp Ser Immunobiol Stand 1967;5:133-48
  • Halket JM, Waterman D, Przyborowska AM, et al. Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS. J Exp Bot 2005;56(410):219-43
  • Wilson ID, Plumb R, Granger J, et al. HPLC-MS-based methods for the study of metabonomics. J Chromatogr B: Anal Technol Biomed Life Sci 2005;817(1):67-76
  • Pan Z, Raftery D. Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal Bioanal Chem 2007;387(2):525-7
  • Chen H, Pan Z, Talaty N, et al. Combining desorption electrospray ionization mass spectrometry and nuclear magnetic resonance for differential metabolomics without sample preparation. Rapid Commun Mass Spectrom 2006;20(10):1577-84
  • Crockford DJ, Holmes E, Lindon JC, et al. Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. Anal Chem 2006;78(2):363-71
  • Crockford DJ, Maher AD, Ahmadi KR, et al. 1H NMR and UPLC-MSE statistical heterospectroscopy: characterization of drug metabolites (Xenometabolome) in epidemiological studies. Anal Chem (Washington, DC, USA) 2008;80(18):6835-44
  • Dumas M-E, Canlet C, Debrauwer L, et al. Selection of biomarkers by a multivariate statistical processing of composite metabonomic data sets using multiple factor analysis. J Proteome Res 2005;4(5):1485-92
  • Pan Z, Gu H, Talaty N, et al. Principal component analysis of urine metabolites detected by NMR and DESI-MS in patients with inborn errors of metabolism. Anal Bioanal Chem 2007;387(2):539-49
  • Powers R. NMR metabolomics and drug discovery. Magn Reson Chem 2009; published online(5 Jun 2009)
  • Robertson DG, Reily MD, Baker JD. Metabonomics in pharmaceutical discovery and development. J Proteome Res 2007;6(2):526-39
  • Wishart DS. Applications of metabolomics in drug discovery and development. Drugs R D 2008;9(5):307-22
  • Stoyanova R, Brown TR. NMR spectral quantitation by principal component analysis. NMR Biomed 2001;14(4):271-7
  • Halouska S, Chacon O, Fenton RJ, et al. Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: role of D-alanine racemase. J Proteome Res 2007;6(12):4608-14
  • Forgue P, Halouska S, Werth M, et al. NMR metabolic profiling of Aspergillus nidulans to monitor drug and protein activity. J Proteome Res 2006;5(8):1916-23
  • Lienemann K, Ploetz T, Pestel S. NMR-based urine analysis in rats: prediction of proximal tubule kidney toxicity and phospholipidosis. J Pharmacol Toxicol Methods 2008;58(1):41-9
  • Clarke CJ, Haselden JN. Metabolic profiling as a tool for understanding mechanisms of toxicity. Toxicol Pathol 2008;36(1):140-7
  • Park J-C, Hong Y-S, Kim YJ, et al. A metabonomic study on the biochemical effects of doxorubicin in rats using 1H-NMR spectroscopy. J Toxicol Environ Health A 2009;72(6):374-84
  • Shi C, Wu C-Q, Cao A-M, et al. NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats. Toxicol Lett 2007;173(3):161-7
  • Dieterle F, Schlotterbeck G, Ross A, et al. Application of metabonomics in a compound ranking study in early drug development revealing drug-induced excretion of choline into urine. Chem Res Toxicol 2006;19(9):1175-81
  • Cui Q, Lewis IA, Hegeman AD, et al. Metabolite identification via the madison metabolomics consortium database. Nat Biotechnol 2008;26(2):162-4
  • Robinette SL, Zhang F, Bruschweiler-Li L, Bruschweiler R. Web server based complex mixture analysis by NMR. Anal Chem (Washington, DC, Us) 2008;80(10):3606-11
  • Wishart DS, Tzur D, Knox C, et al. HMDB: the Human Metabolome Database. Nucleic Acids Res 2007;35(Database Iss):D521-6
  • Frishman D, Mokrejs M, Kosykh D, et al. The PEDANT genome database. Nucleic Acids Res 2003;31(1):207-11
  • Mewes HW, Frishman D, Gueldener U, et al. MIPS: a database for genomes and protein sequences. Nucleic Acids Res 2002;30(1):31-4
  • Thomas PD, Kejariwal A, Campbell MJ, et al. PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res 2003;31(1):334-41
  • Bernal A, Ear U, Kyrpides N. Genomes OnLine Database (GOLD): a monitor of genome projects world-wide. Nucleic Acids Res 2001;29(1):126-7
  • Black MT, Hodgson J. Novel target sites in bacteria for overcoming antibiotic resistance. Adv Drug Deliv Rev 2005;57(10):1528-38
  • Jensen LJ, Gupta R, Staerfeldt HH, Brunak S. Prediction of human protein function according to gene ontology categories. Bioinformatics 2003;19(5):635-42
  • Pouliot Y, Gao J, Su QJ, et al. DIAN: a novel algorithm for genome ontological classification. Genome Res 2001;11(10):1766-79
  • Brenner SE. Target selection for structural genomics. Nat Struct Biol 2000;7(Suppl):967-9
  • Buysse JM. The role of genomics in antibacterial target discovery. Curr Med Chem 2001;8(14):1713-26
  • Kramer R, Cohen D. Functional genomics to new drug targets. Nat Rev Drug Discov 2004;3(11):965-72
  • Roses AD, St Jean PL, Ehm MG. Use of whole-genome association scans in disease gene identification, drug discovery and development. IDrugs 2007;10(11):797-804
  • Powers R, Copeland J, Mercier K. Application of FAST-NMR in drug discovery. Drug Discov Today 2008;13(3-4):172-9
  • Mercier KA, Baran M, Ramanathan V, et al. FAST-NMR: Functional Annotation Screening Technology using NMR Spectroscopy. J Am Chem Soc 2006;128(47):15292-9
  • Livingstone CD, Barton GJ. Protein sequence alignments: a strategy for the hierarchical analysis of residue conservation. CABIOS Comput Appl Biosci 1993;9(6):745-56
  • Mirny LA, Shakhnovich EI. Universally conserved positions in protein folds: reading evolutionary signals about stability, folding kinetics and function. J Mol Biol 1999;291(1):177-96
  • Gerlt JA, Babbitt PC. Divergent evolution of enzymatic function: mechanistically diverse superfamilies and functionally distinct suprafamilies. Annu Rev Biochem 2001;70:209-46
  • Hajduk PJ, Huth JR, Fesik SW. Druggability indices for protein targets derived from NMR-based screening data. J Med Chem 2005;48(7):2518-25
  • English AC, Groom CR, Hubbard RE. Experimental and computational mapping of the binding surface of a crystalline protein. Protein Eng 2001;14(1):47-59
  • Allen KN, Bellamacina CR, Ding X, et al. An experimental approach to mapping the binding surfaces of crystalline proteins. J Phys Chem 1996;100(7):2605-11
  • Liepinsh E, Otting G. Organic solvents identify specific ligand-binding sites on protein surfaces. Nat Biotechnol 1997;15(3):264-8
  • Takai-Igarashi T, Kaminuma T. A pathway finding system for the cell signaling networks database. In Silico Biol 1999;1(3):129-46
  • Kanehisa M, Goto S, Kawashima S, et al. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004;32(Database):D277-80
  • Krieger CJ, Zhang P, Mueller LA, et al. MetaCyc: a multiorganism database of metabolic pathways and enzymes. Nucleic Acids Res 2004;32(Database):D438-42
  • Gubernator K, Boehm HJ. Examples of active areas of structure based-design. Methods Princ Med Chem 1998;6:15-36
  • Kubinyi H. Structure-based design of enzyme inhibitors and receptor ligands. Curr Opin Drug Discov Devel 1998;1(1):4-15
  • Sintchak MD, Nimmesgern E. The structure of inosine 5′-monophosphate dehydrogenase and the design of novel inhibitors. Immunopharmacology 2000;47(2-3):163-84
  • Mihelich ED, Schevitz RW. Structure-based design of a new class of anti-inflammatory drugs: secretory phospholipase A2 inhibitors, SPI. Biochim Biophys Acta Mol Cell Biol Lipids 1999;1441(2-3):223-8
  • Mercier KA, Shortridge M, Powers R. A multi-step NMR screen for the identification and evaluation of chemical leads for drug discovery. Comb Chem High Throughput Screen 2009;12(3):285-95
  • Powers R, Copeland JC, Germer K, et al. Comparison of protein active site structures for functional annotation of proteins and drug design. Proteins Struct Funct Bioinform 2006;65(1):124-35
  • Mercier Kelly A, Cort John R, Kennedy Michael, et al. Structure and function of Pseudomonas aeruginosa protein PA1324 (21-170). Protein Sci 2009;18(3):606-18
  • Shortridge MD, Powers R. Structural and functional similarity between the bacterial type III secretion system needle protein PrgI and the eukaryotic apoptosis Bcl-2 proteins. PLoS ONE 2009; submitted
  • Lee GM, Craik CS. Trapping moving targets with small molecules. Science (Washington, DC, US) 2009;324(5924):213-5
  • Boehr DD, McElheny D, Dyson HJ, Wright PE. The dynamic energy landscape of dihydrofolate reductase catalysis. Science (Washington, DC, US) 2006;313(5793):1638-42
  • Mauldin RV, Carroll MJ, Lee AL. Dynamic dysfunction in dihydrofolate reductase results from antifolate drug binding: modulation of dynamics within a structural state. Structure (Cambridge, MA, US) 2009;17(3):386-94
  • Lange OF, Lakomek N-A, Fares C, et al. Recognition dynamics up to microseconds revealed from an RDC-derived ubiquitin ensemble in solution. Science (Washington, DC, US) 2008;320(5882):1471-5
  • Teague SJ. Implications of protein flexibility for drug discovery. Nat Rev Drug Discov 2003;2(7):527-41
  • Moy FJ, Chanda PK, Chen J, et al. Impact of mobility on structure-based drug design for the MMPs. J Am Chem Soc 2002;124(43):12658-9
  • Zintsmaster JS, Wilson BD, Peng JW. Dynamics of ligand binding from 13C NMR relaxation dispersion at natural abundance. J Am Chem Soc 2008;130(43):14060-1
  • Peng JW. Communication breakdown: protein dynamics and drug design. Structure (Cambridge, MA, US) 2009;17(3):319-20
  • Palmer AG. NMR characterization of the dynamics of biomacromolecules. Chem Rev (Washington, DC, US) 2004;104(8):3623-40
  • Terstappen GC, Schluepen C, Raggiaschi R, Gaviraghi G. Target deconvolution strategies in drug discovery. Nat Rev Drug Discov 2007;6(11):891-903
  • Strausberg RL, Schreiber SL. From knowing to controlling: a path from genomics to drugs using small molecule probes. Science (Washington, DC, US) 2003;300(5617):294-5
  • Dalvit C, Ardini E, Fogliatto GP, et al. Reliable high-throughput functional screening with 3-FABS. Drug Discov Today 2004;9(14):595-602
  • Bista M, Kowalska K, Janczyk W, et al. Robust NMR screening for lead compounds using tryptophan-containing proteins. J Am Chem Soc 2009;131(22):7500-1
  • D'Silva L, Ozdowy P, Krajewski M, et al. Monitoring the effects of antagonists on protein-protein interactions with NMR spectroscopy. J Am Chem Soc 2005;127(38):13220-6
  • Dalvit C, Fagerness PE, Hadden DTA, et al. Fluorine-NMR experiments for high-throughput screening: theoretical aspects, practical considerations, and range of applicability. J Am Chem Soc 2003;125(25):7696-703
  • Moy FJ, Haraki K, Mobilio D, et al. MS/NMR: a structure-based approach for discovering protein ligands and for drug design by coupling size exclusion chromatography, mass spectrometry, and nuclear magnetic resonance spectroscopy. Anal Chem 2001;73(3):571-81
  • Zartler ER, Hanson J, Jones BE, et al. RAMPED-UP NMR: multiplexed NMR-based screening for drug discovery. J Am Chem Soc 2003;125(36):10941-6
  • Shuker SB, Hajduk PJ, Meadows RP, Fesik SW. Discovering high-affinity ligands for proteins: SAR by NMR. Science (Washington, DC) 1996;274(5292):1531-4
  • Jahnke W, Ruedisser S, Zurini M. Spin label enhanced NMR screening. J Am Chem Soc 2001;123(13):3149-50

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.